 Jun 15, 2009
Cenix BioScience expands relationship with AstraZeneca, signing multi-project research agreement |
Mar 19, 2009
Cenix BioScience follows up successful RNAi-based target discovery screens with target validation study for AstraZeneca. |
 Feb 2, 2009
Cenix BioScience Signs Research Agreement with Boehringer Ingelheim for RNAi-Based Target Discovery |
 Nov 17, 2008
InteRNA Technologies and Cenix BioScience Ink Research Agreement for miRNA Drug Discovery |
 Nov 11, 2008
IMM, Cenix and Alnylam Discover New Targets in Malaria Infection with RNAi Technology |
Sep 11, 2008
Instituto de Medicina Molecular, Cenix BioScience, and Alnylam Pharmaceuticals discover new pathway for malaria infection |
 Jul 21, 2008
Cenix BioScience Signs Research Agreement with Regulus Therapeutics for miRNA-Targeted Drug Discovery |
 Jul 1, 2008
Following success of pilot, Cenix BioScience takes on second RNAi-Based Target Validation project for CellCentric |
Mar 20, 2008
Cenix BioScience and CellCentric Sign Framework Research Agreement for RNAi-Based Target Validation |
Mar 19, 2008
Cenix BioScience Signs Framework Research Agreement with AstraZeneca for RNAi-Based Drug Discovery |
 Feb 12, 2008
Cenix BioScience Expands Usage of Definiens Technology in High-Content Screening |
 Feb 12, 2008
Biotechnology Leader Speeds Research With TIBCO Spotfire Enterprise Analytics Platform |
 Jan 30, 2007
Siena Biotech commissions Cenix BioScience to carry out HT-RNAi discovery project on neurodegenerative disease |
 Oct 23, 2006
Cenix BioScience, Applied Biosystems and Dresden University to create a New Facility for Proteomics Profiling of RNAi and Drug Effects in Human Cells
English | German |
 Sep 27, 2006
Cenix BioScience and Merck KGaA Sign Framework Agreement for RNAi-Based Drug Discovery |
 Oct 25, 2005
Following Success of Pilot, Cenix BioScience and Schering AG enter into Agreement on Multiple RNAi-based Target Validation Projects |
 Aug 9, 2005
Cenix BioScience Delivers on Target Discovery Collaboration as Bayer HealthCare AG Acquires Potential Novel Therapeutic Targets Identified by RNAi Screening |
 Jul 12, 2005
Hunt for human genes involved in cell division under way: EMBL starts screening genome-wide siRNA library in EU project MitoCheck |
 Jun 29, 2005
Cenix BioScience and The Instituto de Medicina Molecular Initiate First Genome-Scale RNAi Screen for Novel Malaria Genes |
 May 9, 2005
Definiens and Cenix BioScience Enter into Licensing and Co-Marketing Agreement in High-Content Screening |
 Mar 24, 2005
Cenix BioScience Publishes Comprehensive Genome-Wide RNAi Screen of C. elegans Cell Division Genes and Releases Full Dataset Online |
Feb 28, 2005
Cenix BioScience and Schering AG Sign Research Agreements to Advance Several Disease Programs |
 Aug 2, 2004
Ambion and Cenix release the Drosophila RNAi library, fulfilling the broadest RNAi library product line available |
 May 11, 2004
Cenix BioScience moves into new, state of the art facilities in Dresden's BioInnovation Center |
 Jan 27, 2004
Cenix BioScience announces appointment of Zisi Fotev as new Chief Business Officer |
 Jan 13, 2004
Alnylam and Cenix BioScience enter into research alliance and licensing agreement in RNA interference |
Dec 15, 2003
Cenix BioScience Announces Collaboration with Bayer HealthCare AG to Discover and Validate Novel Therapeutic Targets using Genomic High Throughput RNAi in Human Cells |
 Oct 17, 2003
Cenix co-founder Anthony Hyman receives EMBO Gold Medal 2003 |
 Sep 24, 2003
Dr. Christophe Echeverri named one of the world's top young innovators by Technology Review, MIT's magazine of innovation |
Aug 26, 2003
Ambion and Cenix BioScience announce availability of pre-designed siRNAs covering the human, mouse and rat genomes
English | German |
Mar 24, 2003
Ambion and Cenix BioScience partner to offer first commercially-available human genome-wide siRNA library
English | German |
 Sep 10, 2002
Cenix BioScience raises &euro 5 million in international financing round
English | German |
